Contracts › HT942524C0021
HT942524C0021: Dha Sequential Phase Ii Small Business Innovation Research Contract for Medical Research and Development Project Titled, "Modular Stabilization of Whole Blood Components for Reconstitution and Transfusion at the Point of Injury"
Awarded to Luna Labs Usa Llc by Defense Health Agency.
$1.3Mobligated
$1.3Mpotential value
24 November 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HT942524C0021 |
|---|---|
| Awardee | Luna Labs Usa Llc |
| Awarding agency | Defense Health Agency |
| Awarding office | DEFENSE HEALTH AGENCY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | VA |
| Offers received | 3 |
| Period of performance | 25 March 2024 to 24 November 2026 |
| Potential end | 24 November 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record